Updated Mechanisms of IL-6 in Human Endothelial Cells

Area of Science:

• Cell Biology
• Immunology
• Vascular Biology

Background:

• Interleukin-6 (IL-6) is a cytokine implicated in inflammation and vascular remodeling.
• Its precise role and downstream targets in endothelial cell (EC) angiogenesis remain incompletely understood.

Purpose of the Study:

• To investigate the pro-angiogenic effects of IL-6 in human umbilical vein endothelial cells (HUVECs) and human microvascular endothelial cells (HMEC-1).
• To elucidate the molecular mechanisms and cell-type-specific responses underlying IL-6-mediated angiogenesis.

Main Methods:

• Endothelial cell migration (wound healing assay) and tube formation assays were performed.
• Proteomic analysis identified IL-6-responsive factors.
• Quantitative real-time PCR (qRT-PCR), ELISA, and Western blot validated gene and protein expression.
• Flow cytometry assessed cell surface receptor expression.

Main Results:

• IL-6 significantly enhanced EC migration, tube formation, and blood vessel formation in vivo.
• Proteomic analysis identified Pentraxin 3 (PTX3) as an IL-6-responsive factor, with increased expression in HUVECs but decreased expression in HMEC-1 cells.
• IL-6 stimulation led to increased gp130 gene expression and IL-6 receptor alpha (IL-6Rα) surface expression in both cell types.

Conclusions:

• IL-6 exhibits pro-angiogenic properties in human endothelial cells.
• IL-6-induced PTX3 expression is cell-type-specific.
• Sustained IL-6 signaling is supported by upregulation of its receptor components.